Dominic Tyer (European Pharmaceutical Review)2025-09-22T13:55:33
The CHMP hands the cancer drug two new recommendations, and the FDA approves its subcutaneous use as Keytruda Qlex.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-09-02T14:00:00Z
Sponsored by FUJIFILM Wako Chemicals Europe GmbH
2026-06-29T06:00:00
Sponsored by Lubrizol Advanced Materials Europe BV
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-04-30T10:47:00
Sponsored by CPhI
2026-02-25T15:00:00
Sponsored by Particle Measuring Systems
2025-07-25T08:10:00
Sponsored by JRS Pharma and Gattefosse, European Pharmaceutical Review
Site powered by Webvision Cloud